open mobile menu

Accelerate Time-To-Market With a Proven Team of GI Experts

Tap into our extensive network of 5,000+ sites, leveraging exclusive data from central imaging projects in endoscopy and histopathology, and benefit from our team of medical and operational GI experts for swift study startup and accelerated patient recruitment.
5,000+ sites in 65+ countries
Supporting >70% of IBD compounds currently in development
Unrivaled KOL network

Therapeutic Focus

Alimentiv stands at the forefront of patient recruitment and imaging innovations for gastrointestinal and liver diseases, driving health breakthroughs through advanced research, accelerated clinical trials, and delivering actionable biomarker insights. We are dedicated to redefining the future of GI and liver clinical research.

IBD
EGID/EoE
Celiac
Hepatology

Services

With over 30 years of pioneering advancements in gastrointestinal therapeutics, Alimentiv continues to advance clinical trials through medical research, development, and imaging solutions. Our team offers streamlined solutions for all stages of clinical development, from early phase 1 to phase 4 trials.

Clinical Trial Services
Medical Imaging Solutions
Precision Medicine
Medical Research & Development
Statistics
Real-World Evidence
Specialty Histopathology Lab
Spatial Biology

Latest Updates

News Nov 26, 2025
Honouring the life of Dr. Brian Feagan

Nov 25, 2025 – It is with profound sadness that we share the passing of our friend and colleague, Dr. Brian Feagan. Our hearts are...

News Sep 29, 2025
Alimentiv Experts Share Latest Advancements in GI Clinical Trials at UEG Week 2025

September 29, 2025 – Alimentiv Inc. (“Alimentiv”) is pleased to announce its participation in the highly anticipated European Gastroenterology Week (UEGW) 2025, taking place from...

Article Aug 5, 2025
Advancing Celiac Disease Clinical Trials

Why Standardized Trial Design Is Critical for Patient Outcomes With over 1% of the global population affected by celiac disease, the necessity for efficacious pharmacological...

See All Updates

Speak to a member
of our expert team

Contact us